NU-MED PLUS, INC.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Apr 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | — | — | $0 | — | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $8.1K | — | — | $4.8K | — | $5.5K | $5.7K |
| Operating Income | — | $-22.6K | — | — | $-13.2K | — | $-10.4K | $-18.7K |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $19.7K | — | — | — | — | $-11.7K | — |
| Income Tax Expense | — | $0 | — | — | $0 | — | $0 | — |
| Net Income | — | $19.7K | — | — | $-15.9K | — | $-11.7K | $-19.9K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | $0.00 | — | — | $0.00 | — | $0.00 | $0.00 |
| EPS (Diluted) | — | $0.00 | — | — | — | — | $0.00 | — |
| Shares Outstanding (Basic) | 83.5M | 83.5M | 83.5M | 83.5M | 83.5M | 83.5M | 83.5M | 83.5M |
| Shares Outstanding (Diluted) | 83.5M | 83.5M | 83.5M | 83.5M | 83.5M | 83.5M | 83.5M | 83.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |
The intelligent investor is a realist who sells to optimists and buys from pessimists.